AI assistant
Sending…
CARVANA CO. — Director's Dealing 2025
Dec 13, 2025
30038_dirs_2025-12-12_50571411-933d-49c2-8604-7a0b616836b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CARVANA CO. (CVNA)
CIK: 0001690820
Period of Report: 2025-12-11
Reporting Person: BREAUX PAUL W. (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | Class A Common Stock | M | 8473 | $10.07 | Acquired | 77762 | Direct |
| 2025-12-11 | Class A Common Stock | S | 8473 | $475 | Disposed | 69289 | Direct |
| 2025-12-12 | Class A Common Stock | M | 1527 | $10.07 | Acquired | 70816 | Direct |
| 2025-12-12 | Class A Common Stock | S | 1527 | $475 | Disposed | 69289 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-11 | Stock Options (Right to Buy) | $10.07 | M | 8473 | Disposed | 2033-02-22 | Class A Common Stock (8473) | Direct |
| 2025-12-12 | Stock Options (Right to Buy) | $10.07 | M | 1527 | Disposed | 2033-02-22 | Class A Common Stock (1527) | Direct |
Footnotes
F1: The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2025 (the "10b5-1 Plan").
F2: The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vested 25% on April 1, 2024 and vest monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer.
More from CARVANA CO.
Interim / Quarterly Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Mar 25
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3